111, Inc. Sponsored ADR (NASDAQ:YI) Short Interest Update

111, Inc. Sponsored ADR (NASDAQ:YI) was the recipient of a significant decline in short interest during the month of May. As of May 31st, there was short interest totalling 3,700 shares, a decline of 32.7% from the May 15th total of 5,500 shares. Currently, 0.1% of the shares of the stock are short sold. Based on an average daily volume of 20,000 shares, the days-to-cover ratio is currently 0.2 days.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in YI. FIL Ltd acquired a new position in shares of 111 in the 4th quarter valued at $450,000. Napean Trading & Investment Co Singapore PTE Ltd purchased a new position in shares of 111 in the 4th quarter worth $245,000. JPMorgan Chase & Co. boosted its holdings in 111 by 43,619.9% in the fourth quarter. JPMorgan Chase & Co. now owns 306,039 shares of the company’s stock valued at $191,000 after acquiring an additional 305,339 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in 111 during the first quarter valued at about $92,000. Finally, Deuterium Capital Management LLC purchased a new stake in 111 during the first quarter valued at about $81,000. Hedge funds and other institutional investors own 21.32% of the company’s stock.

111 Stock Down 0.1%

Shares of NASDAQ:YI opened at $8.11 on Wednesday. The company has a market capitalization of $70.07 million, a P/E ratio of -12.67 and a beta of 0.47. 111 has a 52-week low of $4.15 and a 52-week high of $12.90. The stock’s fifty day simple moving average is $7.92 and its 200-day simple moving average is $7.57.

111 (NASDAQ:YI) last released its earnings results on Thursday, March 20th. The company reported ($0.04) earnings per share (EPS) for the quarter. The business had revenue of $527.14 million for the quarter.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of 111 in a research note on Wednesday, June 11th.

111 Company Profile

111, Inc engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies.